Student-community projects receive St. Louis Impact funding
The Gephardt Institute for Civic and Community Engagement has awarded $80,000 in St. Louis Impact Fund grants to advance regional priorities. Students will partner with the St. Louis Science Center, Monarch Immigration Services, Seed St. Louis and other nonprofits.
WashU Medicine researchers win NIH Replication Prize
Aaron Y. Lee, Cecilia S. Lee and Scott A. Handley, all at WashU Medicine, were recognized for their work to improve the speed and reproducibility of clinical research.
Finding order in the inner chaos of our cells
WashU Medicine researchers have developed a technique to synthesize shape-shifting “disordered proteins,” creating new opportunities to understand the basis of disease and design potential medical interventions.
Gordon receives Gabbay Award
Jeffrey I. Gordon, MD, the Dr. Robert J. Glaser Distinguished University Professor at WashU Medicine, has received the Gabbay Award from Brandeis University in recognition of his outstanding contributions to the field of gut microbiome research.
Proven childhood obesity treatment also works at pediatrician’s office
A clinical trial co-led by WashU Medicine researchers found that adding family-based behavioral treatment to specialized pediatric care helped nearly half of children with obesity reach a healthier weight.
Bateman, Horie recognized for method to detect, stage Alzheimer’s disease
WashU Medicine researchers Randall J. Bateman, MD, and Kanta Horie, PhD, received the 2026 Jeffrey L. Morby Prize from Cure Alzheimer’s Fund for developing a blood test that detects and stages Alzheimer’s by measuring toxic proteins in the brain.
Wu named Pew Biomedical Scholar
WashU Medicine molecular microbiologist Meng Wu was honored for her research on how early-life gut microbes shape lifelong immunity.
Three new genetic modifiers connected to risk in Alzheimer’s disease
WashU Medicine researchers and collaborators discovered three new chromosomal locations that may be connected to earlier disease onset or faster disease progression in dominantly inherited Alzheimer’s disease, pointing to new directions for Alzheimer’s research.
WashU announces new academic-industry collaboration with Bristol Myers Squibb
WashU and Bristol Myers Squibb have formed a multiyear collaboration to advance drug development projects in the neurosciences. WashU medical and research trainees will have opportunities to work alongside the company’s scientists at its facilities as part of the agreement.
Benzinger, Schindler honored by international imaging society
Tammie L.S. Benzinger, MD, PhD, and Thomas H. Schindler, MD, PhD, both of WashU Medicine’s Mallinckrodt Institute of Radiology, have been recognized with prestigious awards from the Society for Nuclear Medicine & Molecular Imaging.
View More Stories